Cellular membranes and plasma lipoproteins are less efficiently protected against oxidative stress than the various aqueous compartments of mammalian organisms. Here, previous results on the role of plasmalogens in lipid oxidation are evaluated on the basis of criteria required for an antioxidant. The plasmalogen-specific enol ether double bond is targeted by a vast variety of oxidants, including peroxyl radicals, metal ions, singlet oxygen and halogenating species. Oxidation of the vinyl ether markedly prevents the oxidation of highly polyunsaturated fatty acids, and products of plasmalogen degradation do not propagate lipid oxidation. This protection is also demonstrated intramolecularly, thus ascertaining the function of plasmalogens as a major storage pool for polyunsaturated fatty acids. Although cells rapidly incorporate and synthesize plasmalogens de novo, their plasmalogen contents can be deliberately increased by supplementation with precursors. Thus plasmalogens terminate lipid-oxidation processes, are present in adequate locations at sufficient concentrations, and are rapidly regenerated, classifying them as efficient antioxidants in vitro. Future work should address the in vivo role of plasmalogens in lipid oxidation and the biological function of plasmalogen interactions with oxidants.
Introduction
Peroxidation of lipids has been proposed to promote the development of several common diseases, including atherosclerosis [1] , and neurodegenerative disorders, such as Alzheimer's disease [2] . This has fostered research into the endogenous antioxidant mechanisms capable of preventing or delaying lipid oxidation. In most organisms, the initiation of oxidation processes by oxygen radicals is thought to occur within aqueous environments. In the case of mammalian organisms, these compartments are generally equipped with a vast array of efficient antioxidants (e.g. ascorbic acid or uric acid), which in many cases are present in substantial concentrations (up to the millimolar range). However, some oxidants apparently escape the protecting systems, thereby eventually initiating the peroxidation of lipids. Indeed, as can be appreciated from the presence of a complex spectrum of different lipid oxidation products, there is a continuous and noticeable oxidation of lipids even under physiological conditions [3] .
Within the lipid compartments, antioxidant protection is apparently less efficient than in the aqueous environments. While there is general agreement that α-tocopherol represents the major lipid-soluble protecting system, other hydrophobic antioxidants, such as β-carotene or ubichinol, are usually present in considerably lower concentrations than α-tocopherol, and often react with only a restricted number of oxidant species. However, when compared with the amount of polyunsaturated fatty acids, the major oxidizable substrates in the lipidic compartments (i.e. cellular membranes, lipoproteins and surface layers), the α-tocopherol concentrations might be considered to be rather low. Indeed, the molar ratio of polyunsaturated fatty acids to α-tocopherol in low-density lipoproteins (LDLs) [4] is exceedingly high. Thus there is a dramatic difference in the concentrations and efficiency of antioxidant defence systems between the aqueous and lipidic compartments, pointing to a clear evolutionary priority for the water-soluble antioxidants. Nevertheless, it is likely that there are further antioxidants within the lipidic compartments that so far have not been revealed.
Substantial evidence accumulated in the last decade indicates that plasmalogens, a class of ethanolamine (and choline) phospholipids, could represent a major lipid-soluble antioxidant component [5] [6] [7] [8] [9] [10] [11] . This proposal is based on the ability of the plasmalogens to scavenge several reactive oxygen species, their relatively high concentrations in many animal species (which markedly exceeds the α-tocopherol concentrations) and their subcellular and extracellular locations in close vicinity to the oxidizable substrates (see below). The potential biological functions of plasmalogens have recently been reviewed [12, 13] . However, recent evidence also suggests that the canonical type of ethanolamine phospholipids, the unsaturated diacyl phosphatidylethanolamine, could act as an important pro-oxidant factor [14] . Thus phosphatidylethanolamine, an abundant phospholipid fraction carrying most of the polyunsaturated fatty acids in many organisms, could be a branching point for lipid oxidation, either inhibiting or propagating oxidation depending on the type of subgroup initially targeted by the oxidants.
Structure, biosynthesis and localization of plasmalogens
The structural peculiarity of plasmalogens lies in the enol ether double bond present within the hydrocarbon chain linked to the C-1 atom of the glycerol backbone of phospholipids. This plasmalogen-specific double bond has long been known to react with oxidants [15] . Plasmalogen biosynthesis starts from dihydroxyacetone phosphate (DHAP), which is esterified with long-chain acyl-CoA by DHAP acyltransferase. Next, the long-chain fatty acid at the C-1 atom is replaced by a long-chain fatty alcohol, introducing an ether bond at sn-1, the responsible enzyme being alkyl-DHAP synthase. Then, the ketone at sn-2 is reduced by acyl/alkyl-DHAP reductase, followed by the insertion of a fatty acid in position C-2 catalysed by lysophosphatidate acyltransferase. After removal of the phosphate moiety at the C-3 atom by phosphatidate phosphohydrolase, the phosphoethanolamine head group is attached at the same site by CDP-ethanolamine:diacylglycerol ethanolamine phosphotransferase. Subsequently, the essential and final step in the biosynthesis enables the alkyl bond to be converted into an alkenyl bond (at sn-1), which is accomplished by plasmanylethanolamine desaturase [16] . As for some other components of the biosynthetic machinery, this latter enzyme still awaits identification at the gene level, which is required to assess the biological functions of plasmalogens under in vivo conditions.
In cellular membranes (e.g. plasma membrane and the endoplasmic reticulum), plasmalogens form about 15-20% of all phospholipids [13] , whereas in human lipoproteins their concentration is approx. 5% of total phospholipids [7, 17] . Whereas plasmalogens contain either ethanolamine or choline head groups, in nearly all cell types, the content in ethanolamine plasmalogens exceeds the choline plasmalogens by approx. 10-fold. Cardiac muscle cells represent an apparently singular exception [18] . Importantly, in most cell types, the C-2 atom in ethanolamine and choline plasmalogens is esterified with a highly polyunsaturated fatty acid, containing four or more double bonds. Thus plasmalogens represent the principal pool for polyunsaturated fatty acids in cellular membranes, and therefore, whenever a plasmalogen molecule is targeted by an oxidant, an intramolecular competition occurs between the enol ether double bond and the fatty acid double bonds for reaction with the oxidants.
Interactions of plasmalogens with oxidants
Several oxidizing conditions have been shown to result in the degradation of plasmalogens, both in biological environments and in vitro. The oxidants known to elicit the plasmalogen degradation include peroxyl radicals [8, 19] , UV light [6] , transition-metal ions [9, 10, [19] [20] [21] , and others. The direct reaction of oxidants with the enol ether double bond of plasmalogens has been unambiguously demonstrated by in vitro studies in micelles using 1 H-NMR spectroscopy [8] [9] [10] . Notably, when phospholipids esterified with polyunsaturated fatty acids were included in the micelles, the oxidative loss of the bisallylic double bonds was substantially delayed. The presence of one enol ether double bond was sufficient to markedly prevent the oxidation of the four double bonds contained within arachidonic acid. This was evident both for the polyunsaturated fatty acids esterified to the plasmalogen themselves and for those attached to other types of phospholipids. For every two peroxyl radicals generated, one enol ether bond was shown to be lost [8] . Moreover, for the reaction of plasmalogens with transitionmetal ions, a binding stoichiometry of 1:1 (copper atom:enol ether) was obtained [9] . Interestingly, the reaction of copper with the enol ether was found to prevent the reduction of Cu 2 + to Cu + induced by α-tocopherol [9] , which is thought to account for the pro-oxidative effects of vitamin E. These findings could essentially be corroborated at a higher state of biological complexity, namely in human LDL particles [7, 22, 23] . Again, the oxidation elicited by various oxidants was found to promote the degradation of the plasmalogenspecific enol ether double bond. Supplementation of the lipoproteins with plasmalogens prevented reactions of the oxidants with the fatty acid double bonds, as evident from the decreases in the amount of conjugated double bonds generated. Thus plasmalogens were characterized to fulfil the requirements for a chain-breaking antioxidant.
At the cellular level, the absence of plasmalogens has been shown to sensitize cells to the cytotoxic damage caused by UV light and other oxidants [5, 6] . Normal sensitivity against the cytotoxic influence could be regained by restoring the plasmalogen levels in the same cells [5] . In addition, plasmalogens protected cells against oxidative stress during hypoxia [24] . The reactions implicated in the oxidative degradation of the plasmalogens are only partially defined. It has been proposed that oxygen radicals may abstract a hydrogen atom from the enol ether, ultimately resulting in the decomposition of plasmalogens into aldehydes and lysophospholipids [6] . Allylic hydroperoxides, epoxides and hemiacetals have been proposed as intermediates [6, 25, 26] . Recently, chlorinating and brominating radical species generated by neutrophil myeloperoxidase and eosinophil peroxidase were shown to target the vinyl ether, resulting in the formation of chloro-and bromo-aldehydes. The products thus generated are proposed to represent biologically relevant signalling molecules [27, 28] . These interesting observations could pave the way to a new understanding of the biological role of plasmalogen-oxidant interactions.
Oxidative degradation of plasmalogens in disease
In pathologies that are known to be accompanied by enhanced lipid oxidation, decreased levels of plasmalogens have been noted, including hyperlipidaemia [29] and uraemia [30] . Therapeutic correction of hypercholesterolaemia by LDL apheresis was accompanied by an increase in plasmalogen contents [21] . The augmented lipid oxidation in Alzheimer's disease may enhance the oxidative decomposition of plasmalogens, since reduced plasmalogen contents in afflicted areas have been found at an early stage of the pathology [31, 32] . However, it remains to be established whether this is indeed due to non-enzymic degradation or, rather, is caused by activation of a plasmalogen-specific phospholipase A 2 [33] .
Examining the antioxidant function of plasmalogens by stringent criteria
Antioxidants are compounds capable of reacting with oxidants, whereby the oxidation of substrates present in substantially higher concentrations compared with the antioxidants is either delayed or prevented. When analysing the antioxidant capacity of plasmalogens, the following criteria should be considered (see [34] ).
Direct reaction with oxidants
Many oxidants directly react with the enol ether bond (see above), whereby the oxidative degradation of polyunsaturated fatty acids is considerably delayed. Thus plasmalogens possess a rather broad affinity towards several biologically relevant oxidants.
Antioxidant potency towards different oxidants
As judged from their ability to delay transition-metalinduced oxidation in model systems, the antioxidant potency of α-tocopherol appears to be higher than that of the plasmalogens. However, this difference is less pronounced in LDL particles [9] . The ability of the plasmalogens to diminish the oxygen consumption by polyunsaturated fatty acids is a relevant argument for its classification as an antioxidant [35] .
Concentrations in comparison with those of oxidizable substrates
Compared with the number of oxidizable substrates, the concentration of plasmalogens is substantially lower. For example, in LDL, the number of enol ether double bonds is approx. two orders of magnitude lower than the number of double bonds of polyunsaturated fatty acids (assuming 25 plasmalogen molecules per LDL particle; [4] ).
Adequate concentrations in a biological setting
Compared with the total concentrations of other lipophilic antioxidants, plasmalogen concentrations are considerably higher [10] . Since, concomitantly, the affinity towards various oxidants appears to be in a similar range as that of α-tocopherol, it is assumed that their antioxidant capacity in vivo should be of considerable relevance.
Lack of a pro-oxidant effect of degradation products
At present, plasmalogens are known to widely fulfil this essential criterion under in vitro conditions. The oxidation of even high concentrations of plasmalogens by peroxyl radicals does not generate oxidation products capable of promoting the oxidation of polyunsaturated fatty acids [8, 9] . The aldehydes generated by the oxidation of the enol ether are likely to be metabolized by cellular enzymes (dehydrogenases), yielding innocuous degradation products.
Adequate location
The antioxidant should be located in the vicinity of the oxidizable substrate, at all levels in a biological system (molecular, cellular, etc.). Within cellular membranes and lipoproteins, plasmalogens are indeed located in close proximity to the double bonds of polyunsaturated fatty acids, even affording an intramolecular protection for their own fatty acids.
Suitability of regeneration
It is largely unknown how the alkenyl chain might be regenerated after oxidative degradation at the molecular level. Since ethanolamine plasmalogens appear to be rapidly taken up by cells, especially when compared with the ester analogue [36, 37] , plasmalogens most probably are also rapidly recruited from extracellular sources. Moreover, in vivo, the plasmalogen levels can be increased by supplementation with adequate precursors [38, 39] .
Ability for regeneration of other antioxidants
So far, it is not known whether plasmalogens are able to regenerate other antioxidants, comparable with the regeneration of α-tocopherol by ascorbic acid. However, plasmalogens have been shown to prevent the transformation of α-tocopherol into a chain-propagating oxidant [9] .
Antioxidant efficiency in vivo
The studies described above strongly suggest that the antioxidant capacity of plasmalogens is at least as pronounced as that of α-tocopherol. Nevertheless, a general analysis of the role of plasmalogens in vivo will be required to evaluate the role of plasmalogens in lipid oxidation adequately, e.g., by identification of the gene coding for the plasmanylethanolamine desaturase and the generation of animal models deficient in the enzyme.
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